SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)
Clinical trial NCT06009029 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06009029
- Sponsor
- Peking University Third Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2026-07-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.